Anti-D initially stimulates an Fc-dependent leukocyte oxidative burst and subsequently suppresses erythrophagocytosis via interleukin-1 receptor antagonist

Blood

Volumn 102, Issue 8, 2003, Pages 2862-2867

  Coopamah, Malini D ^b   Freedman, John ^b   Semple, John W ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FC RECEPTOR; HYDROGEN PEROXIDE; HYDROXYL GROUP; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; PEROXYNITRITE; RHESUS D ANTIBODY; SUPEROXIDE;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; DOSE RESPONSE; ERYTHROCYTE; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; INCUBATION TIME; INFLAMMATION; LEUKOCYTE; MEASUREMENT; MONOCYTE; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; REGULATORY MECHANISM; RESPIRATORY BURST; THROMBOCYTOPENIC PURPURA; TITRIMETRY;

EID: 0141889306     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-04-1029     Document Type: Article

References (30)

1. Blanchette VS, Semple JW, Freedman J. Intravenous immunoglobulin and Rh immunoglobulin as immunomodulators of autoimmunity to blood elements. In: Silberstein LE, ed. Autoimmune Disorders of Blood. Bethesda, MD: American Association of Blood Banks; 1996:35-77.
2. Imbach P, Barandun, S, d'Apuzzo V, et al. High dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet. 1981;1:1228-1231.
3. Fehr J, Hofmann V, Kappeler U. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gammaglobulin. N Engl J Med. 1982;306:1254-1258.
4. Rossi F, Kazatchkine MD. Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig. J Immunol. 1989;143:4104-4109.
5. Andersson JP, Andersson UG. Human intravenous gammaglobulin modulates monokine production in vitro. Immunology. 1990;71:372-376.
6. Samulesson A, Towers TL, Ravetch JV. Anti-inflammatory activity of IVIg mediated through the inhibitory Fc receptor. Science. 2001;291:484-486.
7. Salama A, Kiefel V, Amberg R, Mueller-Eckhardt C. Treatment of autoimmune thrombocytopenic purpura with rhesus antibodies (anti-Rh0(D)]. Blut. 1984;49:29-35.
8. Kumpel BM, Elson CJ. Mechanism of acti-D-mediated suppression - a paradox awaiting resolution. Trends Immunol. 2001;22:26-31.
9. Semple JW, Allen D, Hogarth M, et al. In vivo actions of Anti-D (WinRho SD) in children with chronic autoimmune thrombocytopenic purpura (AITP) [abstract]. Blood. 1998;92(suppl 1):178a.
10. Semple JW, Allen, D, Rutherford M, et al. Anti-D (WinRho SD) treatment of children with chronic autoimmune thrombocytopenic purpura stimulates transient cytokine/chemokine production. Am J Hematol. 2002;69:225-227.
11. Bussel J, Heddle N, Richards C, Woloski M. MCP-1, IL10, IL-6 and TNF-α levels in patients with ITP before and after IV anti-D and IVIg treatments [abstract]. Blood. 1999;94(suppl 1):15a.
12. Malinowska I, Obitko-Pludowska A, Buescher ES, Wasik M, Rokicka-Milewska R. Release of cytokines and soluble cytokine receptors after intravenous anti-D treatment in children with chronic thrombocytopenic purpura. Hematol J. 2001;2:242-249.
13. Semple JW, Kim M, Lazarus AH, Freedman J. γ-Globulins prepared from sera of multiparous women bind anti-HLA antibodies and inhibit an established in vivo human alloimmune response. Blood. 2002;100:1055-1059.
14. Aukrust P, Muffer F, Nordoy I, Haug CJ, Froland SS. Modulation of lymphocyte and monocyte activity after intravenous immunoglobulin administration in vivo. Clin Exp Immunol. 1997;107:50-56.
15. Nakatani K, Takeshita S, Tsujimoto H, Sekine I. Intravenous immunoglobulin (IVIG) preparations induce apoptosis in TNF-alpha-stimulated endothelial cells via a mitochondria-dependent pathway. Clin Exp Immunol. 2002;127:445-454.
16. Halliwell BC, Veronique, Hua LL. Hydrogen peroxide in the human body. FEBS Lett 2000;486:10-13.
17. Tanaka K, Usui Y, Kojo S. Role of serum components in the binding and phagocytosis of oxidatively damaged erythrocytes by autologous mouse macrophages. Cell Mol Life Sci. 2001;58:1727-1733.
18. Bratosin D, Mazurier J, Tissier JP, et al. Cellular and molecular mechanisms of senescent erythrocyte phagocytosis by macrophages: a review. Biochimie. 1998;80:173-195.
19. Loegering DJ, Raley MJ, Reho TA, Eaton JW. Macrophage dysfunction following the phagocytosis of IgG-coated erythrocytes: production of lipid peroxidation products. J Leukoc Biol. 1996;59:357-362.
20. Aulenbacher P, Paweletz N, Friedrich E, Süss R. Studies on intravascular phagocytosis in the lung. Virchows Arch B Cell Pathol Incl Mol Pathol. 1983;44:57-64.
21. Nusbacher J, MacPherson JL, Gore I Jr, Grinberg R. Inhibition of granulocyte erythrophagocytosis by HLA antisera. Blood. 1979;53:350-357.
22. Eisenberg G, Evans RJ, Arend P, et al. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature. 1990;343:341-346.
23. Carter DB, Deibel MR, Dunn CJ, et al. Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature. 1990;344:633-638.
24. Hannum CH, Wilcox CJ, Arend WP, et al. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature. 1990;343:336-340.
25. Granowitz EV, Clark BD, Mantilla J, Dinarello CA. Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor. J Biol Chem. 1991;266:14147-14150.
26. Dripps DJ, Verderber E, Ng RK, Thompson RC, Eisenberg SP. Interleukin-1 receptor antagonist binds to the type II interleukin-1 receptor on B cells and neutrophils. J Biol Chem. 1991;266:20311-20315.
27. Dripps DJ, Brandhuber BJ, Thompson RC, Eisenberg SP. Interleukin-1 (IL1) receptor antagonist binds to the 80kDa IL1 receptor but does not initiate IL1 signal transduction. J Biol Chem. 1991;266:10331-10336.
28. Aukrust P, Froland SS, Liabakk NB, et al. Release of cytokines, soluble cytokine receptors and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo. Blood. 1994;84:2136-2143.
29. Sewell WAC, Jolles S. Immunomodulatory action of intravenous immunoglobulin. Immunology. 2002;107:387-393.
30. Davenport RD, Burdick MD, Strieter RM, Kinkel SL. In vitro production of interleukin-1 receptor antagonist in IgG-mediated red cell incompatibility. Transfusion. 1994;34:297-303.